Swiss National Bank’s Castle Biosciences CSTL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.11M | Hold |
54,300
| – | – | ﹤0.01% | 2101 |
|
|
2025
Q1 | $1.09M | Buy |
54,300
+3,000
| +6% | +$60.1K | ﹤0.01% | 2091 |
|
|
2024
Q4 | $1.37M | Hold |
51,300
| – | – | ﹤0.01% | 2065 |
|
|
2024
Q3 | $1.46M | Hold |
51,300
| – | – | ﹤0.01% | 2030 |
|
|
2024
Q2 | $1.12M | Buy |
51,300
+1,100
| +2% | +$23.9K | ﹤0.01% | 2120 |
|
|
2024
Q1 | $1.11M | Hold |
50,200
| – | – | ﹤0.01% | 2163 |
|
|
2023
Q4 | $1.08M | Sell |
50,200
-5,000
| -9% | -$108K | ﹤0.01% | 2197 |
|
|
2023
Q3 | $932K | Hold |
55,200
| – | – | ﹤0.01% | 2280 |
|
|
2023
Q2 | $757K | Buy |
55,200
+6,800
| +14% | +$93.3K | ﹤0.01% | 2438 |
|
|
2023
Q1 | $1.1M | Sell |
48,400
-5,500
| -10% | -$125K | ﹤0.01% | 2196 |
|
|
2022
Q4 | $1.27M | Buy |
53,900
+1,000
| +2% | +$23.5K | ﹤0.01% | 2201 |
|
|
2022
Q3 | $1.38M | Buy |
52,900
+2,100
| +4% | +$54.8K | ﹤0.01% | 2131 |
|
|
2022
Q2 | $1.12M | Buy |
50,800
+2,900
| +6% | +$63.7K | ﹤0.01% | 2302 |
|
|
2022
Q1 | $2.15M | Buy |
47,900
+3,600
| +8% | +$162K | ﹤0.01% | 1999 |
|
|
2021
Q4 | $1.9M | Hold |
44,300
| – | – | ﹤0.01% | 2099 |
|
|
2021
Q3 | $2.95M | Buy |
44,300
+600
| +1% | +$39.9K | ﹤0.01% | 1796 |
|
|
2021
Q2 | $3.21M | Buy |
43,700
+2,300
| +6% | +$169K | ﹤0.01% | 1795 |
|
|
2021
Q1 | $2.83M | Buy |
41,400
+500
| +1% | +$34.2K | ﹤0.01% | 1800 |
|
|
2020
Q4 | $2.75M | Buy |
40,900
+14,800
| +57% | +$994K | ﹤0.01% | 1731 |
|
|
2020
Q3 | $1.34M | Buy |
26,100
+500
| +2% | +$25.7K | ﹤0.01% | 1922 |
|
|
2020
Q2 | $965K | Buy |
+25,600
| New | +$965K | ﹤0.01% | 2126 |
|